What may be the closest thing yet to a timely silver bullet for HLB was discussed Oct. 26 at Lake Alfred’s Citrus Research and Education Center. Josh Steinbronn, director of research and development at TJ BioTech, said trunk injection of his company’s ReMedium TI oxytetracycline product suppresses Candidatus Liberibacter asiaticus (CLas), the causal agent of HLB. He added that injection of the product significantly …
 |  |  |  |  |  |  |  |  |
Tag Archive
Below you'll find a list of all posts that have been tagged as “Josh Steinbronn”